Methamphetamine – Gateway Drug to Parkinson’s Disease

Proudly supported by

Play icon

Methamphetamine - Gateway Drug to Parkinson's Disease


  Last updated November 21, 2017 at 2:48 pm


Methamphetamine already has a terrible reputation for being addictive and detrimental to mental and physical health. But what’s lesser known is it causes permanent neuron damage resulting in the same movement problems as Parkinson’s Disease. Dr Gabrielle Todd, Senior Lecturer in Neuroscience from UniSA’s School of Pharmacy and Medical Sciences has been researching the link between meth, movement and Parkinson’s Disease, and she’s impatient to share the whole story.

Find the original research here.

Published By

Science and technology is as much a part of our cultural fabric as art, music, theatre and literature. They play a significant role in our daily lives, yet, in a world dependent on science, we often take them for granted. Australia’s Science Channel believes every citizen has a right, and a responsibility, to be informed, and our mission is to create programs to bring that about.